1. Pan X F, Li Y, Franco O H, Yuan J M, Pan A, Koh W P. (2019). Impact of combined lifestyle factors on all-cause and cause-specific mortality and life expectancy in Chinese: the Singapore Chinese Health Study. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glz271
2. Hansen D, Niebauer J, Cornelissen V, Barna O, Neunhäuserer D, Stettler C, Tonoli C, Greco E, Fagard R, Coninx K, Vanhees L, Piepoli M F, Pedretti R, Ruiz G R, Corrà U, Schmid J P, Davos C H, Edelmann F, Abreu A, Rauch B, Ambrosetti M, Braga S S, Beckers P, Bussotti M, Faggiano P, Garcia-Porrero E, Kouidi E, Lamotte M, Reibis R, Spruit M A, Takken T, Vigorito C, Völler H, Doherty P, Dendale P. (2018). Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group. Sports Med, 48(8): 1781-1797. https://doi.org/10.1007/s40279-018-0930-4
3. Hartley L, Mavrodaris A, Flowers N, Ernst E, Rees K. (2017). WITHDRAWN: Transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev, 11(11): CD010359. https://doi.org/10.1002/14651858.CD010359.pub3
4. Davari A, Solouki M, Fazeli-Nasab B. (2018). Effects of jasmonic acid and titanium dioxide nanoparticles on process of changes of phytochemical and antioxidant in genotypes of Satureja hortensis L. Eco-Phytochemical Journal of Medicinal Plants, 5(4): 1-20 (In Persian).
5. Sharifi-Rad J, Rodrigues C F, Sharopov F, Docea A O, Can Karaca A, Sharifi-Rad M, Kahveci Karıncaoglu D, Gülseren G, Şenol E, Demircan E, Taheri Y, Suleria H A R, Özçelik B, Nur Kasapoğlu K, Gültekin-Özgüven M, Daşkaya-Dikmen C, Cho W C, Martins N, Calina D. (2020). Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds. Int J Environ Res Public Health, 17(7). https://doi.org/10.3390/ijerph17072326
6. Salehi B, Del Prado-Audelo M L, Cortés H, Leyva-Gómez G, Stojanović-Radić Z, Singh Y D, Patra J K, Das G, Martins N, Martorell M, Sharifi-Rad M, Cho W C, Sharifi-Rad J. (2020). Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases. J Clin Med, 9(3). https://doi.org/10.3390/jcm9030746
7. Ali M A, Islam M A, Othman N H, Noor A M, Hossen J, Ibrahim M. (2019). Effect of Heating on Compositional Characteristics and Oxidative Stability of Crude and Refined Rice Bran Oil. J Oleo Sci, 68(11): 1085-1097. https://doi.org/10.5650/jos.ess19140
8. Kobayashi E, Ito J, Kato S, Sawada K, Matsuki M, Hashimoto H, Miyazawa T, Nakagawa K. (2016). Presence of orally administered rice bran oil γ-oryzanol in its intact form in mouse plasma. Food Funct, 7(12): 4816-4822. https://doi.org/10.1039/c6fo01552b
9. Sohail M, Rakha A, Butt M S, Iqbal M J, Rashid S. (2017). Rice bran nutraceutics: A comprehensive review. Crit Rev Food Sci Nutr, 57(17): 3771-3780. https://doi.org/10.1080/10408398.2016.1164120
10. Rahman M, Zaman M, Islam A S. (2011). Prospect of rice bran oil production in Bangladesh. J Agril Engg, 39(1): 1-8.
11. Deshpande A B, Chidley H G, Oak P S, Pujari K H, Giri A P, Gupta V S. (2016). Data on changes in the fatty acid composition during fruit development and ripening of three mango cultivars (Alphonso, Pairi and Kent) varying in lactone content. Data in brief, 9: 480-491. https://doi.org/10.1016/j.dib.2016.09.018
12. Sugano M, Tsuji E. (1997). Rice bran oil and cholesterol metabolism. J Nutr, 127(3): 521S-524S. https://doi.org/10.1093/jn/127.3.521S
13. Al-Okbi S Y, Mohamed D A, Hamed T E, Al-Siedy E S. (2019). Rice bran as source of nutraceuticals for management of cardiovascular diseases, cardio-renal syndrome and hepatic cancer. Journal of Herbmed Pharmacology, 9(1): 68-74. https://doi.org/10.15171/jhp.2020.10
14. Lei L, Chen J, Liu Y, Wang L, Zhao G, Chen Z Y. (2018). Dietary Wheat Bran Oil Is Equally as Effective as Rice Bran Oil in Reducing Plasma Cholesterol. J Agric Food Chem, 66(11): 2765-2774. https://doi.org/10.1021/acs.jafc.7b06093
15. Sunitha T, Manorama R, Rukmini C. (1997). Lipid profile of rats fed blends of rice bran oil in combination with sunflower and safflower oil. Plant Foods Hum Nutr, 51(3): 219-230. https://doi.org/10.1023/a:1007993016796
16. Khanna A K, Rizvi F, Chander R. (2002). Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol, 82(1): 19-22. https://doi.org/10.1016/s0378-8741(02)00136-8
17. Devi R, Sharma D K. (2004). Hypolipidemic effect of different extracts of Clerodendron colebrookianum Walp in normal and high-fat diet fed rats. J Ethnopharmacol, 90(1): 63-68. https://doi.org/10.1016/j.jep.2003.09.022
18. Anila L, Vijayalakshmi N R. (2002). Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol, 79(1): 81-87. 10.1016/s0378-8741(01)00361-0
19. Araghi A, Seifi S, Sayrafi R, Sadighara P. (2016). Safety assessment of rice bran oil in a chicken embryo model. Avicenna J Phytomed, 6(3): 351-356.
20. Shimomura Y, Kobayashi I, Maruto S, Ohshima K, Mori M, Kamio N, Fukuda H. (1980). Effect of gamma-oryzanol on serum TSH concentrations in primary hypothyroidism. Endocrinol Jpn, 27(1): 83-86. https://doi.org/10.1507/endocrj1954.27.83